Investors

Share

July 6, 2011, Grandhope Biotech successfully listed on Shenzhen GEM (growth enterprise market), with the stock code 300238. The share circulation of this time is 1,530 million, with the price of 18.20 RMB per share and the P/E ratio of 38.16.

 

The money raised from the shares is mainly used for the construction of the“National Engineering Laboratory for Regenerative Implantable Medical Devices” and the “State’s High-tech Industrialization Demonstration Project”, as well as the development of the marketing network and other operation projects.

 

Chairman Zhu made a speech on the ceremony of listing. He said that, “To list on the Shenzhen GEM is a new milestone of the development of Grandhope. In the future, Grandhope will face more opportunities and challenges. And Grandhope promises to take the responsibility and strives without reserve to be a world-renowned pioneer in the field of regenerative implantable medical devices.”

SitemapQR code

Copyright 2015 冠昊生物科技股份有限公司. 粤ICP备12069953号
互联网药品信息服务资格证书编号:(粤)-非经营性-2011-0176